{"id":"suclear","safety":{"commonSideEffects":[{"rate":null,"effect":"Photosensitivity"},{"rate":null,"effect":"Skin reactions at treatment site"},{"rate":null,"effect":"Pain at injection site"}]},"_chembl":{"chemblId":"CHEMBL2021423","moleculeType":"Small molecule","molecularWeight":"120.37"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"SUCLEAR functions as a photosensitizer that accumulates in tumor tissue and, when activated by specific wavelengths of light, produces singlet oxygen and other reactive oxygen species that cause direct cytotoxic damage to cancer cells and associated vasculature. This mechanism allows for localized tumor destruction with reduced systemic toxicity compared to conventional chemotherapy.","oneSentence":"SUCLEAR is a photodynamic therapy agent that generates reactive oxygen species upon light activation to selectively destroy cancer cells.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:36:39.026Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Solid tumors (Phase 3 development)"}]},"trialDetails":[{"nctId":"NCT02551198","phase":"PHASE3","title":"Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2015-11-01","conditions":"Healthy","enrollment":184},{"nctId":"NCT03520361","phase":"PHASE4","title":"Comparison Between OSS and 2L PEG/Asc for Bowel Preparation of Elderly People","status":"UNKNOWN","sponsor":"KangWon National University Hospital","startDate":"2017-11-02","conditions":"Colonoscopy","enrollment":198}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["oral sulfate solution; OSS,"],"phase":"phase_3","status":"active","brandName":"SUCLEAR®","genericName":"SUCLEAR®","companyName":"National Cancer Center, Korea","companyId":"national-cancer-center-korea","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SUCLEAR is a photodynamic therapy agent that generates reactive oxygen species upon light activation to selectively destroy cancer cells. Used for Solid tumors (Phase 3 development).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}